Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QAV680 in mild to moderate persistent asthma
NCT00814216Phase 2Completed
- Sponsor
- Novartis
- Start
- Dec 2008
- Primary completion
- Oct 2009
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of QAV680 in asthma, sponsored by Novartis. Started Dec 2008; status: completed.
02
Drugs
QAV680
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00814216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814216.